Albert Ko, MD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Albert Icksang Ko is the Raj and Indra Nooyi Professor of Public Health at the Yale School of Public Health and a Collaborating Researcher at the Oswaldo Cruz Foundation, Brazilian Ministry of Health. His research centers on the health problems that have emerged as a consequence of rapid urbanization and social inequity. Dr. Ko coordinates a research program in Brazil, which focuses on delineating the role of social marginalization, urban ecology and climate in the emergence of infectious disease threats in slum communities and informal settlements. He and his team have mobilized research capacity to develop and implement community-based interventions to epidemics of meningitis, leptospirosis, dengue, Zika virus infection and associated birth defects, and the current COVID-19 pandemic. Dr. Ko is also Program Director of the Fogarty/NIH Global Health Equity Scholars Program which provides research training opportunities for US and LMIC post and pre-doctoral fellows at collaborating international sites. He is a member of the WHO R&D Taskforce for Zika Virus and R&D Blueprint Working Group. During the pandemic, he served with Indra Nooyi as co-chair of Governor Lamont’s Reopen Connecticut Advisory Group. Dr. Ko continues to advise the Governor and the State on its pandemic prevention and control plan, in addition to supporting the Oswaldo Cruz Foundation in its COVID-19 response in Brazil.
Education & Training
- Postdoctoral FellowWeill Medical College of Cornell University (1997)
- Infectious Disease FellowMassachusetts General Hospital (1997)
- ResidentBrigham and Women's Hospital (1994)
- MDHarvard Medical School (1991)
- BSMassachusetts Institute of Technology (1981)
Activities
- Zoonotic Disease and One Health ResearchBangkok, Thailand 2015
- Emerging Infectious Diseases and UrbanizationSalvador, Brazil 1995The Division of International Medicine and Infectious Disease, Weill Medical College of Cornell University (Cornell) has had a joint training and research program on endemic tropical diseases with Brazilian institutions in the city of Salvador since the 1964. More recently, the investigations of Cornell and its Brazilian collaborators have brought to attention infectious diseases, such as epidemic leptospirosis, which have emerged in the urban setting due to rapid urbanization and increasing social inequality. Through the Fogarty-sponsored International Training in Emerging Infectious Diseases (ITREID) Program, we have been established at the Oswaldo Cruz Foundation (Fiocruz), Brazilian Ministry of Health in Salvador: 1) a multidisciplinary team of epidemiologists, clinicians, microbiologists and basic researchers, 2) on-going population-based surveillance for leptospirosis and bacterial meningitis; 2) a diagnostic laboratory that is now the national reference center for leptospirosis surveillance; 3) a molecular strain typing center, and 4) field sites to perform community-based longitudinal studies designed to identify determinants of transmission for leptospirosis and the etiologic pathogens for bacterial meningitis. Moreover, ITREID projects have convinced the Brazilian government to prioritize emerging infectious diseases such as leptospirosis, and in turn have led to national projects to sequence the Leptospira genome and develop a vaccine against leptospirosis. The infrastructure created at Fiocruz since 1996 provides a vehicle to pursue multidisciplinary training approaches for emerging infectious diseases. In this program, we are using leptospirosis and bacterial meningitis as disease models to address the following specific objectives: 1) Expand training opportunities that will provide Brazilian trainees at the Oswaldo Cruz Foundation (Fiocruz) the capacity to develop treatment, control and prevention strategies for emerging infectious diseases; and 2) Work jointly with the Brazilian Ministry of Health to disseminate expertise already established at Fiocruz in laboratory-based surveillance, outbreak investigations and molecular epidemiology to other regions of Brazil. The program emphasizes the use of in-country expertise and resources to provide training. For the first aim, we proposed long-term training to 6 predoctoral and 2 postdoctoral fellows each year to address specific needs in expertise within the areas of clinical and field epidemiology, molecular epidemiology, pathogenesis and biotechnology application to develop public health interventions. In-country training provided by outstanding Brazilian mentors will be augmented with short training experiences in the institutions of long-standing US collaborators. For the second aim, Fiocruz is working with the National Center of Epidemiology, Brazilian Ministry of Health in providing short-term training opportunities and a yearly course, the National Course in Molecular Epidemiology in Emerging Infectious Diseases, which are designed to enhance the capacity of local public health epidemiologists and reference laboratory staff to perform laboratory-based surveillance and apply molecular strain typing tools to epidemiological investigations.
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Member | Association of American Physicians | 2021 |
Member | Connecticut Academy of Science and Engineering | 2020 |
Fellow | American Society of Tropical Medicine and Hygiene | 2019 |
Charles F. Craig Lecture | American Society of Tropical Medicine and Hygiene | 2016 |
Fellow | American College of Physicians | 2014 |
Fellow | Infectious Disease Society of America | 2008 |
Special Citation for Fellow-in-Training | Infectious Disease Society of North America | 1997 |
Arnold Dunne Award | Brigham and Women's Hospital | 1992 |
Member | Sigma Xi | 1981 |
Professional Service
Organization | Role | Date |
---|---|---|
Inaugural Expert Panel, Reckitt Global Hygiene Institute | Board Member | 2020 - Present |
R&D Roadmap for Zika Virus, World Health Organization | Task Force Member | 2019 - Present |
American Society of Tropical Medicine and Hygiene | Member, Board of Directors | 2018 - Present |
Global Virus Network | Member, Zika Task Force | 2016 - Present |
National Institutes of Health | Standing Member, Clinical Research and Field Studies of Infectious Diseases (CRFS) Study Section | 2015 - 2019 |
PLoS Neglected Tropical Disease | Deputy Editor | 2005 - Present |
Urban Health Council of the Resident Associations of Pau da Lima | Founding Member | 2002 - Present |
Departments & Organizations
- Center for Infection and Immunity
- Climate Change and Health
- CPIRT - Pulmonary Infection Research and Treatment
- Epidemiology of Microbial Diseases
- Global Health Studies
- Infectious Diseases
- Internal Medicine
- Microbiology
- Office of Cooperative Research
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Institute for Global Health
- Yale Medicine
- Yale School of Public Health
- YSPH Global Health Concentration